Furthermore, pharmacologic reversion of PRKD1 methylation with the DNA methyltransferase inhibitor decitabine restored PKD1 expression and reduced tumor invasion and metastasis to lungs in an animal model (Borges et al., 2013). This evidence concerns the gene PRKD1 and neoplasm.